FOLH1 and neoplasm: Based on our dosimetry calculations, we identified kidney as activity-limiting organ and recommended 6.0 GBq as an appropriate activity for the initial 177Lu-PSMA-617 RLT cycle [6], giving high tumor dosing without excessive irradiation of vulnerable healthy organs.